Drupal.behaviors.print = function(context) {window.print();window.close();}>
Castle Biosciences to Add to Orphan Cancer Dx Menu with IU Thymoma Gene License
January 26, 2012
Castle Biosciences to Add to Orphan Cancer Dx Menu with IU Thymoma Gene License
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Castle Biosciences Licenses IP for Thymoma Test
January 25, 2012 / GenomeWeb Daily News
NIPD Genetics Raises €2.5M to Fund Development of Noninvasive Down Syndrome Dx
October 6, 2011 / PCR Insider
Cypriot Group Develops Non-Invasive, Prenatal Down Syndrome Dx; Creates Startup to Market Test
March 10, 2011 / PCR Insider
Qiagen, BioBay Open Translational Medicine Center in China
May 24, 2013 / GenomeWeb Daily News
Roche Unveils Higher-Throughput Cobas Systems as it Maps out MDx Strategy
May 23, 2013 / PCR Insider